News from the FDA/CDC
News from the FDA/CDC
FDA grants breakthrough therapy status to rituximab for pemphigus vulgaris
The FDA designation is based on the results of a recently published French study.
News from the FDA/CDC
CDC reports two new Zika-related pregnancy losses
Since the beginning of 2016, there have been 7 pregnancy losses and 54 infants with birth defects born to Zika-infected women.
News from the FDA/CDC
Zika-infected pregnancies continue to rise in U.S.
Zika-infected pregnancy rates are rising in the United States and falling in the territories.
News from the FDA/CDC
Birth defects in United States up 20-fold since Zika outbreak began
Birth defects commonly associated with prenatal Zika infections in the United States have risen drastically in only a few years.
News from the FDA/CDC
Zika slowing, but not going away
New cases of pregnant women with Zika infection are down, but five more infants born with Zika-related birth defects have been reported.
News from the FDA/CDC
Brodalumab approved for psoriasis with REMS required
The FDA has approved brodalumab for treating moderate to severe psoriasis, with a REMS that addresses a risk of suicidal ideation and behavior...
News from the FDA/CDC
ACIP releases updated guidance for adult vaccinations
Effectiveness of certain flu vaccine formulations may be unacceptably low in certain populations.
News from the FDA/CDC
New Zika-infected pregnancies down for most of United States
New cases of Zika infection in pregnant women were down again for the 50 states over the 2-week reporting period ending Jan. 24, but U.S....
News from the FDA/CDC
Increase brings flu activity back to seasonal high
The level of influenza-like illness activity was highest in five states for the week ending Jan. 21, compared with three states the week before,...
News from the FDA/CDC
FDA approves topical oxymetazoline for rosacea
A topical cream containing the vasoconstrictor oxymetazoline has been approved by the Food and Drug Administration to treat symptoms of rosacea,...
News from the FDA/CDC
Zika virus slowdown continues
Zika activity is slowing as winter progresses, with less than a hundred new cases of pregnant women with laboratory evidence of infection reported...